Antagonistic effect of amphotericin B on carboplatin antitumor activity in human osteosarcoma xenografts

Anti-Cancer Drugs

Volumn 7, Issue 4, 1996, Pages 489-492

  Crnalic, Sead ^a   Bergström, Per ^a   Löfvenberg, Richard ^a   Henriksson, Roger ^a   Broström, Lars Åke ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amphotericin B; Carboplatin; Interaction; Nude mouse; Osteosarcoma

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; CARBOPLATIN; POLYENE ANTIBIOTIC AGENT;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRAFT; CONTROLLED STUDY; DRUG ANTAGONISM; FEMALE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOSARCOMA; PRIORITY JOURNAL; TUMOR GROWTH; XENOGRAFT;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CARBOPLATIN; CELL DIVISION; DRUG INTERACTIONS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; OSTEOSARCOMA; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029888401     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199606000-00015     Document Type: Article

References (18)

1. Ettinger LJ, Gaynon PS, Krailo MD, et al. A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group. Cancer 1994; 73: 1297-301.
2. Van Echo DA, Egorin MJ, Aisner J. The pharmacology of carboplatin. Semin Oncol 1989; 16: 1-6.
3. Brajtburg J, Powderly WG, Kobayashi GS, Medoff G. Amphotericin B: current understanding of mechanisms of action. Antimicrob Agents Chemother 1990; 34: 183-8.
4. Kikkawa F, Kojima M, Oguchi H, et al. Potentiating effect of amphotericin B on five platinum anticancer drugs in human cis-diamminedichloroplatinum (II) sensitive and resistant ovarian carcinoma cells. Anticancer Res 1993; 13: 891-6.
5. Morikage T, Ohmori T, Nishio K, Fujiwara Y, Takeda Y, Saijo N. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines. Cancer Res 1993; 53: 3302-7.
6. Tomayko MM, Reynolds CP. Determination of subcutaneous tumour size in athymic (nude) mice. Cancer Chemother Pharmacol 1989; 24: 148-54.
7. Krishan A, Sauerteig A, Gordon K. Effect of amphotericin B on adriamycin transport in P338 cells. Cancer Res 1985; 45: 4097-102.
8. Vertut-Croquin A, Brajtburg J, Medoff G. Two mechanisms of synergism when amphotericin B is used in combination with actinomycin D or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea against the human promyelocytic leukemia cell line HL-60. Cancer Res 1986; 46: 6054-8.
9. Presant CA, Carr D. Amphotericin B (Fungizone) enhancement of nitrogen mustard uptake by human tumor cells. Biochem Biophys Res Commun 1980; 93: 1067-73.
10. Bergström P, Grankvist K, Holm S, Henriksson R. Effects of antimicrobial drugs on the cytotoxicity of epirubicin, bleomycin, estramustine and cisplatin. Anticancer Res 1991; 11; 1039-44.
11. Sharp SY, Mistry P, Valenti MR, Bryant AP, Kelland LR. Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B. Cancer Chemother Pharmacol 1994; 35: 137-43.
12. Assem M, Bonvalot S, Beltramo JL, et al. Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells. Br J Cancer 1994; 70: 631-5.
13. Chabot G, Pazdur R, Valeriote FA, Baker LA. Pharmacokinetics and toxicity of continuous infusion Amphotericin B in cancer patients. J Pharm Sci 1989; 78: 307-10.
14. Presant GA, Multhauf P, Metter G. Reversal of cancer chemotherapeutic resistance by amphotericin B. A broad phase I-II pilot study. Eur J Cancer Clin Oncol 1987; 23: 683-7.
15. Medoff G, Valeriote F, Dieckman J. Potentiation of anti-cancer agents by amphotericin B. J Natl Cancer Inst 1981; 67; 131-5.
16. Valeriote F, Dickman J, Chabot G. Schedule-dependent potentiation of lomustine cytotoxicity by amphotericin B in mice. J Natl Cancer Inst 1986; 76: 521-5.
17. Chatelut E, Canal P, Brunner V, et al. Prediction of carboplatin clearance from standard morphological and biological patient characteristics. J Natl Cancer Inst 1995; 87; 573-80.
18. Gately DP, Jones JA, Christen R, Barton RM, Los G, Howell SB. Induction of the growth arrest and DNA damage-inducible gene GADD153 by cisplatin in vitro and in vivo. Br J Cancer 1994; 70: 1102-6.